Your browser doesn't support javascript.
loading
CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models.
Lv, Zhuangwei; Zhang, Ping; Li, Dandan; Qin, Mengting; Nie, Longzhu; Wang, Xiaoqian; Ai, Li; Feng, Zhaozu; Odhiambo, Woodvine Otieno; Ma, Yunfeng; Ji, Yanhong.
Afiliação
  • Lv Z; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  • Zhang P; Institute of Infection and Immunity, Xi'an Jiaotong University Translational Medicine Center, Xi'an, China.
  • Li D; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  • Qin M; Institute of Infection and Immunity, Xi'an Jiaotong University Translational Medicine Center, Xi'an, China.
  • Nie L; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  • Wang X; Institute of Infection and Immunity, Xi'an Jiaotong University Translational Medicine Center, Xi'an, China.
  • Ai L; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  • Feng Z; Institute of Infection and Immunity, Xi'an Jiaotong University Translational Medicine Center, Xi'an, China.
  • Odhiambo WO; School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  • Ma Y; The Clinical Laboratory, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Ji Y; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Oncoimmunology ; 9(1): 1747688, 2020.
Article em En | MEDLINE | ID: mdl-32363119
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Linfócitos B / Receptor ErbB-2 / Antígenos CD19 / Vacinas Anticâncer Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Oncoimmunology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Linfócitos B / Receptor ErbB-2 / Antígenos CD19 / Vacinas Anticâncer Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Oncoimmunology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China